• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Syncor's mid-year results improve

Article

Radiopharmacy firm Syncor International reported improving marginson the strength of continued sales growth through the first halfof 1995. Net sales for the six months ended June 30 increased6.1%, to $166.3 million. Net income for the period was $2.3

Radiopharmacy firm Syncor International reported improving marginson the strength of continued sales growth through the first halfof 1995. Net sales for the six months ended June 30 increased6.1%, to $166.3 million. Net income for the period was $2.3 million,compared to $2.8 million in the first half of 1994.

In the second quarter of 1995, net sales increased 1.7% to $83.3million. Net income for the second quarter was $1.3 million, comparedto $700,000 for the same period last year.

Results through June put the company on track to meet Syncor's1995 financial objectives, according to chief executive Gene McGrevin.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.